Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,382 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06677645Recruiting
Temporary nursing home stay after hospital discharge
This study is testing if a short stay in a nursing home or long-term care unit can help older patients who are medically stable but not quite ready to go home after a hospital stay. It looks at how this temporary accommodation affects their recovery and return home.
Cormeilles-en-ParisisAges 60 years+ - NCT06678347Recruiting
Leadership program for healthcare managers
This trial tests a program to help first-line managers in hospitals lead better and support their teams. It may benefit managers and their employees by improving work recovery and well-being.
GothenburgAges 18 years+ - NCT06682169RecruitingPhase 3
New pill for chronic graft-versus-host disease after other treatments fail
This trial tests a new pill called rovadicitinib for chronic GVHD that has not improved after 2 to 5 other treatments. It compares the new drug to one chosen by your doctor from a list of approved options.
Hefei, AnhuiAges 18–70 - NCT06682325Recruiting
Liver transplant drug interaction study
This study looks at how different medicines interact with each other in people who receive a new liver. By analyzing your blood samples and medical records, researchers hope to make your medication safer and more effective after transplant.
Santiago, Santiago MetropolitanAges 18 years+ - NCT06682520Recruiting
Postpartum Support for New Mothers in Rural North Carolina
This study tests a program to provide extra education and support to new mothers after childbirth. It is for women who deliver at a specific birth center or at home and get follow-up care there.
Winston-Salem, North CarolinaAges 18 years+ - NCT06682793RecruitingPhase 1/Phase 2
Study of A2B395 therapy for solid tumors with EGFR and HLA loss
This trial tests a new cell therapy called A2B395 for cancers that have EGFR, a protein on the cell surface, and have lost a specific marker called HLA-A*02. The therapy uses specially engineered immune cells to target and kill these cancer cells. This may help patients with colorectal, lung, head and neck, breast, kidney, or other solid tumors that are no longer responding to standard treatments.
Gilbert, ArizonaAges 18 years+ - NCT06684314Recruiting
Efanesoctocog alfa for long-term joint health in hemophilia A
This study tests how well a new factor VIII medicine, efanesoctocog alfa, protects your joints over time. It's for people with moderate or severe hemophilia A who are just starting this treatment.
ChanghuaAges Any age - NCT06684652Recruiting
Comparing targeted plus standard biopsies for prostate cancer diagnosis
This trial tests whether adding a targeted biopsy to a standard sextant biopsy improves the detection of prostate cancer. It is for men aged 45 to 85 who have a suspicious spot on an MRI of their prostate and have not had a biopsy before.
Beijing, Beijing MunicipalityAges 45–85 - NCT06685523Recruiting
Peri-implantitis study for patients with gum disease around implants
This trial studies a substance called fractalkine and its receptor in the gum fluid around dental implants affected by peri-implantitis. It aims to understand the role of these markers in inflammation, which may help improve diagnosis or treatment.
KirikkaleAges 40–60 - NCT06685562Recruiting
Testing a map to help make cancer decisions together
This study tests a new way to help people with cancer and their doctors make decisions together. If you have prostate, breast, or melanoma cancer, this trial may help you understand your options better.
VejleAges 18 years+ - NCT06685887RecruitingPhase 2
Chemo, Immunotherapy, and Heated Belly Chemo for Stomach Cancer Spread
This trial tests combining standard chemotherapy and immunotherapy (tirelizumab) with heated chemotherapy given directly into the belly. It aims to treat stomach cancer that has spread to the abdominal lining, and may help shrink or control the cancer.
Wuhan, HubeiAges 18–75 - NCT06686251Recruiting
AI assistant for reading chest X-rays in breathing problems
This study tests a computer program that helps doctors read chest X-rays faster and more accurately. It is for adults who had an X-ray because of breathing problems like a cough or fever.
Curitiba, ParanáAges 18 years+ - NCT06686472RecruitingPhase 2
Testing TL-925 eye drops for allergic conjunctivitis
This trial tests an investigational eye drop called TL-925 to see if it can treat allergic conjunctivitis (eye allergies). If you have a history of eye allergies and a positive allergy skin test, you may be able to join.
Memphis, TennesseeAges 18 years+ - NCT06687941RecruitingPhase 1
Trial of AST-201 for GPC3-positive advanced solid tumors
This trial tests a new drug called AST-201 for people with advanced solid tumors that have a specific protein (GPC3). The study aims to see how safe and well-tolerated the drug is, and how the body processes it.
Goyang-si, Gyeonggi-doAges 19 years+ - NCT06689566Recruiting
Genistein for heart attack recovery and inflammation
This study tests whether genistein, a natural compound found in soy, can help reduce inflammation and improve heart health in people who have had a heart attack and are overweight or have other risk factors.
Taipei, TaiwanAges 18 years+ - NCT06689852Recruiting
Study of two treatments for nail fungus
This trial tests two different treatments for fungus that affects the fingernails or toenails. It is designed to see how well the treatments work and if they are safe.
Villeurbanne, FranceAges 18–70 - NCT06691659Recruiting
Testing a new CT scanner with photon-counting technology
This study is testing a new, more advanced type of CT scanner. It uses photon-counting technology to take clearer pictures of the body with less radiation. You will have one or more CT scans to help researchers see how well this new machine works compared to current scanners.
Philadelphia, PennsylvaniaAges 18–89 - NCT06691698Recruiting
CO-OP therapy for teens with mild intellectual disability
This study tests a therapy called CO-OP, which helps teens with mild intellectual disability learn skills to reach their own goals. You'll work with a therapist once a week for 10 weeks, with a parent or adult to support you.
Kristianstad, Skåne CountyAges 13–17 - NCT06691893RecruitingPhase 3
RELiZORB for pancreatic insufficiency in tube-fed pancreatitis
This study tests whether the RELiZORB device (which helps digest fat in tube feedings) can improve symptoms for patients with pancreatitis and pancreatic enzyme insufficiency who are in the hospital and rely on a feeding tube for most of their nutrition.
Boston, MassachusettsAges 18 years+ - NCT06692166RecruitingPhase 3
New drug vs standard chemo for advanced cervical cancer
This trial tests a new drug called 9MW2821 against standard chemotherapy options for cervical cancer that has come back or spread. The goal is to see if the new drug works better than the usual treatments, and you must have already tried a platinum-based chemotherapy.
BeijingAges 18–75 - NCT06693336RecruitingPhase 2
Adjuvant chemotherapy trial for early-stage lung cancer
This trial tests a chemotherapy drug called SMS001 (a form of paclitaxel) after surgery for non-small cell lung cancer. It may help prevent the cancer from coming back.
Rochester, MinnesotaAges 18–80 - NCT06693362RecruitingPhase 1
Stem cell therapy for severe viral pneumonia
This trial tests whether injecting stem cells from the womb's blood supply can help treat severe viral pneumonia. It aims to improve recovery for people who are very sick and need hospital care.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT06693570RecruitingPhase 4
Fish skin graft for hard-to-heal leg ulcers
This trial tests whether applying a special fish skin graft, along with standard compression therapy, helps heal leg ulcers caused by poor vein function (venous leg ulcers) that have not healed with standard care alone. If you have a nonhealing venous leg ulcer, this study may offer a new treatment option.
Monroeville, PennsylvaniaAges 18 years+ - NCT06693934Recruiting
Prevention program for young adults at risk of diabetes
This trial offers a prevention program for young adults aged 18 to 44 who have at least one risk factor for diabetes but do not already have diabetes. The program aims to help prevent or delay the onset of diabetes.
Hong KongAges 18–44
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,382 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.